136 related articles for article (PubMed ID: 17200342)
1. 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis.
Rojo F; Najera L; Lirola J; Jiménez J; Guzmán M; Sabadell MD; Baselga J; Ramon y Cajal S
Clin Cancer Res; 2007 Jan; 13(1):81-9. PubMed ID: 17200342
[TBL] [Abstract][Full Text] [Related]
2. Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer.
Rutkovsky AC; Yeh ES; Guest ST; Findlay VJ; Muise-Helmericks RC; Armeson K; Ethier SP
BMC Cancer; 2019 May; 19(1):491. PubMed ID: 31122207
[TBL] [Abstract][Full Text] [Related]
3. Tumor Necrosis Factor Receptor-2 Signals Clear-Cell Renal Carcinoma Proliferation via Phosphorylated 4E Binding Protein-1 and Mitochondrial Gene Translation.
Al-Lamki RS; Tolkovsky AM; Alawwami M; Lu W; Field SF; Wang J; Pober JS; Bradley JR
Am J Pathol; 2024 Mar; ():. PubMed ID: 38537932
[TBL] [Abstract][Full Text] [Related]
4. High USP6NL Levels in Breast Cancer Sustain Chronic AKT Phosphorylation and GLUT1 Stability Fueling Aerobic Glycolysis.
Avanzato D; Pupo E; Ducano N; Isella C; Bertalot G; Luise C; Pece S; Bruna A; Rueda OM; Caldas C; Di Fiore PP; Sapino A; Lanzetti L
Cancer Res; 2018 Jul; 78(13):3432-3444. PubMed ID: 29691252
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Assessment of Preanalytic Variables on Clinical Evaluation of PI3/AKT/mTOR Signaling Activity in Diffuse Glioma.
Beccari S; Mohamed E; Voong V; Hilz S; Lafontaine M; Shai A; Lim Y; Martinez J; Switzman B; Yu RL; Lupo JM; Chang EF; Hervey-Jumper SL; Berger MS; Costello JF; Phillips JJ
Mod Pathol; 2024 Apr; 37(6):100488. PubMed ID: 38588881
[TBL] [Abstract][Full Text] [Related]
6. Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability.
Huang KL; Wu Y; Primeau T; Wang YT; Gao Y; McMichael JF; Scott AD; Cao S; Wendl MC; Johnson KJ; Ruggles K; Held J; Payne SH; Davies S; Dar A; Kinsinger CR; Mesri M; Rodriguez H; Ellis MJ; Townsend RR; Chen F; Fenyö D; Li S; Liu T; Carr SA; Ding L
Mol Cell Proteomics; 2019 Aug; 18(8):1630-1650. PubMed ID: 31196969
[TBL] [Abstract][Full Text] [Related]
7. Frequent 4EBP1 Amplification Induces Synthetic Dependence on FGFR Signaling in Cancer.
Mohan P; Pasion J; Ciriello G; Lailler N; de Stanchina E; Viale A; van den Berg A; Diepstra A; Wendel HG; Sanghvi VR; Singh K
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626002
[TBL] [Abstract][Full Text] [Related]
8. Britanin - a beacon of hope against gastrointestinal tumors?
Kajdanek A; Kołat D; Zhao LY; Kciuk M; Pasieka Z; Kałuzińska-Kołat Ż
World J Clin Oncol; 2024 Apr; 15(4):523-530. PubMed ID: 38689621
[TBL] [Abstract][Full Text] [Related]
9. 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications.
Armengol G; Rojo F; Castellví J; Iglesias C; Cuatrecasas M; Pons B; Baselga J; Ramón y Cajal S
Cancer Res; 2007 Aug; 67(16):7551-5. PubMed ID: 17699757
[TBL] [Abstract][Full Text] [Related]
10. High
Nelson ED; Benesch MG; Wu R; Ishikawa T; Takabe K
Am J Cancer Res; 2024; 14(1):227-242. PubMed ID: 38323277
[TBL] [Abstract][Full Text] [Related]
11. Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma.
Quddusi DM; Bajcinca N
IET Syst Biol; 2023 Aug; 17(4):143-161. PubMed ID: 37277696
[TBL] [Abstract][Full Text] [Related]
12.
Jang HJ; Lee S; Hong E; Yim KJ; Choi YS; Jung JY; Kim ZH
J Microbiol Biotechnol; 2023 Apr; 33(4):449-462. PubMed ID: 36864505
[TBL] [Abstract][Full Text] [Related]
13. An Autophagy-Associated Prognostic Gene Signature for Breast Cancer.
Cao L; Huang N; Wang J; Lan Z; Wei J; Li F; Li T; Feng Z; Yu L; Zuo S
Biochem Genet; 2023 Aug; 61(4):1282-1299. PubMed ID: 36550211
[TBL] [Abstract][Full Text] [Related]
14. Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancer.
Dai Y; Yang L; Sakandar A; Zhang D; Du F; Zhang X; Zou L; Zhao Y; Wang J; Zhang Z; Wu X; Li M; Ling X; Yu L; Dong L; Shen J; Xiao Z; Wen Q
Front Oncol; 2022; 12():906197. PubMed ID: 36524001
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection.
Tang Y; Luo J; Yang Y; Liu S; Zheng H; Zhan Y; Fan S; Wen Q
PLoS One; 2022; 17(6):e0265465. PubMed ID: 35737644
[TBL] [Abstract][Full Text] [Related]
16. mTOR pathway gene expression in association with race and clinicopathological characteristics in Black and White breast cancer patients.
Ilozumba MN; Yao S; Llanos AAM; Omilian AR; Zhang W; Datta S; Hong CC; Davis W; Khoury T; Bandera EV; Higgins M; Ambrosone CB; Cheng TD
Discov Oncol; 2022 May; 13(1):34. PubMed ID: 35608730
[TBL] [Abstract][Full Text] [Related]
17. HSP60 Regulates Lipid Metabolism in Human Ovarian Cancer.
Li N; Li N; Wen S; Li B; Zhang Y; Liu Q; Zheng S; Yang J; Shen L; Xing L; Zhan X
Oxid Med Cell Longev; 2021; 2021():6610529. PubMed ID: 34557266
[TBL] [Abstract][Full Text] [Related]
18. Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma.
Wang B; Zhang W; Zhang G; Kwong L; Lu H; Tan J; Sadek N; Xiao M; Zhang J; Labrie M; Randell S; Beroard A; Sugarman E; Rebecca VW; Wei Z; Lu Y; Mills GB; Field J; Villanueva J; Xu X; Herlyn M; Guo W
Oncogene; 2021 Sep; 40(37):5590-5599. PubMed ID: 34304249
[TBL] [Abstract][Full Text] [Related]
19. The Role of Processed
Le Phan TH; Park SY; Jung HJ; Kim MW; Cho E; Shim KS; Shin E; Yoon JH; Maeng HJ; Kang JH; Oh SH
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204534
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
